Graphene Quantum Dots Pinned on Nanosheets-Assembled NiCo-LDH Hollow Micro-Tunnels: Toward High-Performance Pouch-Type Supercapacitor via the Regulated Electron Localization.

A combined delicate micro-/nano-architecture and corresponding surface modification at the nanometer level can co-tailor the physicochemical properties to realize an advanced supercapacitor electrode material. Herein, nanosheets-assembled nickel-cobalt-layered double hydroxide (NiCo-LDH) hollow micro-tunnels strongly coupled with higher-Fermi-level graphene quantum dots (GQDs) are reported. The unique hollow structure endows the electrolyte accessible to more electroactive sites, while 2D nanosheets have excellent surface chemistry, which favors rapid ion/electron transfer, synergistically resulting in more super-capacitive activities. The experimental and density functional theory calculations recognize that such a precise decoration generally tunes the charge density distribution at the near-surface due to the Fermi-level difference of two components, thus regulating the electron localization, while decorating with conductive GQDs co-improves the charge mobility, affording superior capacitive response and electrode integrity. The as-acquired GQDs@LDH-2 electrode yields excellent capacitance reaching ≈1628 F g-1 at 1 A g-1 and durable cycling longevity (86.2% capacitive retention after 8000 cycles). When coupled with reduced graphene oxide-based negative electrode, the hybrid device unveils an impressive energy/power density (46 Wh kg-1 / 7440 W kg-1 ); moreover, a flexible pouch-type supercapacitor can be constructed based on this hybrid system, which holds high mechanical properties and stable energy and power output at various situations, showcasing superb application prospects.

Immune-related factors associated with pneumonia in 127 children with coronavirus disease 2019 in Wuhan.

OBJECTIVE: Information regarding the association of immune-related factors with pneumonia in children with coronavirus disease 2019 (COVID-19) is scarce. This study aims to summarize the immune-related factors and their association with pneumonia in children with COVID-19. METHODS: Children with COVID-19 at Wuhan Children's Hospital from 28 January to 12 March 2020 were enrolled. Pneumonia due to causes other than COVID-19 were excluded. The clinical and laboratory information including routine blood tests, blood biochemistry, lymphocyte subsets, immunoglobulins, cytokines, and inflammatory factors were analyzed retrospectively in 127 patients. Normal ranges and mean values of laboratory markers were applied as parameters for logistic regression analyses of their association with pneumonia. RESULTS: In nonintensive care unit patients, 48.8% and 22.4% of patients had increased levels of procalcitonin and hypersensitive C-reactive protein (hs-CRP) respectively. A total 12.6% and 18.1% of patients had decreased levels of immunoglobulin A (IgA) and interleukin 10 (IL-10), respectively. Approximately 65.8% of patients had pneumonia. These patients had decreased levels of globulin (odds ratio [OR], 3.13; 95% confidence interval [CI] 1.41-6.93; P = .005), IgA (OR, 4.00; 95% CI, 1.13-14.18; P = .032), and increased levels of hs-CRP (OR, 3.14; 95% CI, 1.34-7.36; P = .008), procalcitonin (OR, 3.83; 95% CI, 2.03-7.24; P < .001), IL-10 (OR, 7.0; 95% CI, 1.59-30.80; P = .010), and CD4+ CD25+ T lymphocyte less than 5.0% (OR, 1.93; 95% CI, 1.04-3.61; P = 0.038). CONCLUSION: Decreased IgA and CD4+ CD25+ T lymphocyte percentage, and increased hs-CRP, procalcitonin, and IL-10 were associated with pneumonia, suggesting that the immune-related factors may participate in the pathogenesis of pneumonia in children with COVID-19.

Symptomatic Infection is Associated with Prolonged Duration of Viral Shedding in Mild Coronavirus Disease 2019: A Retrospective Study of 110 Children in Wuhan.

BACKGROUND: Information regarding viral shedding in children with coronavirus disease 2019 (COVID-19) was limited. This study aims to investigate the clinical and laboratory characteristics associated with viral shedding in children with mild COVID-19. METHODS: The clinical and laboratory information of 110 children with COVID-19 at Wuhan Children's Hospital, Wuhan, China, from January 30 to March 10, 2020, were analyzed retrospectively. RESULTS: The median age was 6 years old. The median period of viral shedding of COVID-19 was 15 days (interquartile range [IQR], 11-20 days) as measured from illness onset to discharge. This period was shorter in asymptomatic patients (26.4%) compared with symptomatic patients (73.6%) (11 days vs. 17 days). Multivariable regression analysis showed increased odds of symptomatic infection was associated with age <6 years (odds ratio [OR] 8.94, 95% confidence interval [CI]: 2.55-31.35; P = 0.001), hypersensitive C-reactive protein >3.0 mg/L (OR 4.89; 95% CI: 1.10-21.75; P = 0.037) and presenting pneumonia in chest radiologic findings (OR 8.45; 95% CI: 2.69-26.61; P < 0.001). Kaplan-Meier analysis displayed symptomatic infection (P < 0.001), fever (P = 0.006), pneumonia (P = 0.003) and lymphocyte counts <2.0 × 10/L (P = 0.008) in children with COVID-19 were associated with prolonged duration of viral shedding in children with COVID-19. CONCLUSION: Prolonged duration of viral shedding in children with COVID-19 was associated with symptomatic infection, fever, pneumonia and lymphocyte count less than 2.0 × 10/L. Monitoring of symptoms could help to know the viral shedding in children with COVID-19.